EVOKE PHARMA INC (EVOK)
US30049G2030 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to EVOK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 1537.61% above the current price.
EVOK was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EVOK.
In the previous month the buy percentage consensus was at a similar level.
EVOK was analyzed by 7 analysts. More opinions would make the average more meaningful.